E Exclusive Interview With Lindsay Rosenwald, CEO Of Fortress Biotech 


Terry Chrisomalis: Fortress Biotech currently has 5 commercials stage products, and over 25 development stage programs. How do you plan to grow those numbers within the next year? Five years?
Lindsay Rosenwald: Fortress Biotech is always reviewing new drug candidates and discussing potential agreements with other companies and research institutions. One of our goals for the year is to expand our business development group and acquire more drug candidates. We also want to grow our sales and revenues to allow Journey Medical to branch out of the dermatology space. On the development side, we want to see our late-stage product candidates get approved and start bringing in revenues. 

But at the end of the day, we want to keep doing what we’re doing. Fortress Biotech is just getting started and we have a lot to look forward to.


Terry Chrisomalis: How and when do you determine whether to develop a product candidate on your own or look for a strategic partner?
Lindsay Rosenwald: It all comes down to the economics. We look at the value of the drug candidate and whether it’s more productive for Fortress Biotech to develop it alone, or with a strategic partner. If we don’t use a strategic partner, it has to be in a therapeutic area where we’d want to develop our own sales and marketing group.

Terry Chrisomalis: Thank you for your time.

1 2 3 4
View single page >> |

Disclosure: This article is part of a new “UnderCovered” series of exclusive articles featuring companies with limited coverage. Authors are compensated by TalkMarkets for their time, and ...

more
How did you like this article? Let us know so we can better customize your reading experience. Users' ratings are only visible to themselves.

Comments

Leave a comment to automatically be entered into our contest to win a free Echo Show.
Kurt Benson 3 months ago Member's comment

Good article Lindsay A. Rosenwald. Sounds like $FBIO is on the right track. But how might the growing threat of the coronavirus impact your company?

Mike Nolan 3 months ago Member's comment

I'm wondering this as well.

Backyard Hiker 3 months ago Member's comment

Never heard of this company before but I like their business model.

Wall St. Wolf 3 months ago Member's comment

I've liked $FBIO for a while now.

Adam Reynolds 3 months ago Member's comment

$FBIO sounds like a pretty innovative company.